Evidence map›Paper›PMID 40063799›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Amplification-free, OR-gated CRISPR-Cascade reaction for pathogen detection in blood samples.

Jongwon Lim, An Bao Van, Katherine Koprowski, Matthew Wester, Enrique Valera, Rashid Bashir

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. SDS-CRISPR for Single-Nucleotide Variant Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jongwon LimDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
An Bao VanDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.ORCID 0009-0006-1480-0879
Katherine KoprowskiDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Matthew WesterDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.ORCID 0009-0001-1921-9614
Enrique ValeraDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.ORCID 0000-0003-1359-6619
Rashid BashirDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.ORCID 0000-0002-7225-9180

Funding

Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood SpecimensR01EB032725 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI KOHLI, MANISH, SMITH, ANDREW MICHAEL · 2022 to 2025
$2.2M
Point-of-Care Microfluidic Biochip for Biomarkers Monitoring for Contributing in Early Sepsis DiagnosisR01AI148385 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BASHIR, RASHID · 2021 to 2024
$2.1M
Prenatal Care for African American Women: Effect of Client-Provider InteractionF31NR010320 · NINR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAHLEM, CHIN HWA YI · 2007 to 2009
$88k
Dynamic Research Enterprise for Multidisciplinary Engineering Science B7859Jump ARCHES P373NIAID NIH HHS R01 AI148385NIBIB NIH HHS R01 EB032725NINR NIH HHS F31 NR010320VinUni-Illinois Smart Health Center 106709
6 · The paper itself

Abstract

Rapid and accurate detection of DNA from disease-causing pathogens is essential for controlling the spread of infections and administering timely treatments. While traditional molecular diagnostics techniques like PCR are highly sensitive, they include nucleic acid amplification and many need to be performed in centralized laboratories, limiting their utility in point-of-care settings. Recent advances in CRISPR-based diagnostics (CRISPR-Dx) have demonstrated the potential for highly specific molecular detection, but the sensitivity is often constrained by the slow trans-cleavage activity of Cas enzymes, necessitating preamplification of target nucleic acids. In this study, we present a CRISPR-Cascade assay that overcomes these limitations by integrating a positive feedback loop that enables nucleic acid amplification-free detection of pathogenic DNA at atto-molar levels and achieves a signal-to-noise ratio greater than 1.3 within just 10 min. The versatility of the assay is demonstrated through the detection of bloodstream infection pathogens, including Methicillin-Sensitive

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsDNA, BacterialDNA, ViralEscherichia coliHumansMethicillin-Resistant Staphylococcus aureusNucleic Acid Amplification TechniquesPoint-of-Care SystemsSensitivity and SpecificityDNA, BacterialDNA, Viralamplification-free CRISPR diagnosticsbloodstream infectionCRISPR-Cascadepathogen detection

Identifiers

PMID40063799
PMCPMC11929484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.